| Name | Gateway Care Center |
|---|---|
| Location | 139 Grant Ave, Eatontown, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 178 |
| Occupancy Rate | 69.49% |
| Medicare ID (CCN) | 315177 |
| Legal Business Name | Gateway Care Center, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1699769323 |
| Organization Name | GATEWAY CARE CENTER, LLC |
| Address | 139 Grant Ave, Eatontown, NJ 07724 |
| Phone Number | 732-542-4700 |
News Archive
Researchers at Mayo Clinic Center for Individualized Medicine have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumors, a rare soft tissue cancer that does not respond to radiation or chemotherapy.
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
IDEXX Laboratories, Inc., today reported that revenues for the third quarter of 2013 increased 7.2% to $338.3 million, from $315.5 million for the third quarter of 2012.
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA. The announcement was made at the Second Global Forum on TB Vaccine Development.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers at Mayo Clinic Center for Individualized Medicine have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumors, a rare soft tissue cancer that does not respond to radiation or chemotherapy.
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
IDEXX Laboratories, Inc., today reported that revenues for the third quarter of 2013 increased 7.2% to $338.3 million, from $315.5 million for the third quarter of 2012.
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA. The announcement was made at the Second Global Forum on TB Vaccine Development.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 9.18 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.14 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 13.85 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.73 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.73 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.04 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.49 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 88.17 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 3.71 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 59.85 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 5.08 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 13.16 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.73 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.65 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.99 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 69.25 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 58.03 | 82.93 |
News Archive
Researchers at Mayo Clinic Center for Individualized Medicine have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumors, a rare soft tissue cancer that does not respond to radiation or chemotherapy.
University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
IDEXX Laboratories, Inc., today reported that revenues for the third quarter of 2013 increased 7.2% to $338.3 million, from $315.5 million for the third quarter of 2012.
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA. The announcement was made at the Second Global Forum on TB Vaccine Development.
› Verified 3 days ago
Jersey Shore Center Location: 3 Industrial Way East, Eatontown, New Jersey 07724 Phone: (732) 544-1557 |